Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Wednesday
May 22nd
Home arrow Farmavita.Net Journal arrow Human Intestinal Permeability
Human Intestinal Permeability Print E-mail
Life Sciences - Life Science Article

PREDICTION OF HUMAN INTESTINAL PERMEABILITY SINGLE-PASS INTESTINAL PERFUSION IN RAT: A QSAR/QSPR APPROACH

The aim of the study was the prediction of human intestinal permeability and fraction absorbed of oral dose using QSAR/QSPR methods. To explore physicochemical and topological properties of 15 compounds responsible for their Human intestinal permeability, a quantitative structure activity relationship, Hansch approach was applied on sixteen compounds. Various physicochemical and topological descriptors and reported Human intestinal permeability values of different 15 compounds were used as independent variables and dependent variable respectively.

The whole 5 pages article is available for download at Downloads section of Farmavita.Net. 

The best models for 15 different compounds were first validated by Regression analysis. It was revealed that physicochemical parameter Density, polarizability, Molecular Volume, Parachore and topological parameter J play a very significant role to predict the human intestinal permeability and these studies provide an insight to design new molecules.
Drugs are most commonly administered via oral route. In fact the vast majority of pharmaceutical dosage forms are designed for oral administration. However not all of the compounds have compatible properties for the development of oral dosage forms. Often poor bioavailability results in the termination of development of new drugs. Therefore, optimized bioavailability of drugs is one of the most important goals for the pharmaceutical industry.
The two principal routes of absorption across small intestinal epithelium are paracellular and transcellular. Typically, lipophilic drugs are absorbed by the transcellular route, whereas hydrophilic drugs are slowly absorbed via the transcellular pathway or in some cases via the paracellular route. Both passive and active (carrier mediated) processes may contribute to the permeability to drugs transported by the transcellular pathway.  For instance several amino acid analogues such as α-methyldopa, Ldopa  and baclofen are transported by large neutral amino acid transporter and orally absorbed cephalosporins are substrates for the H+/oligopeptide transporter.
The efficiency of drug absorption is also influenced by efflux proteins lining the small intestine. For example Pglycoprotein (P-gp) is a phosphorylated and glycosylated efflux protein belonging to a family of plasma membrane proteins encoded by the multidrug resistance gene(s) (1). It functions as a membrane-localized drug transport mechanism that has the ability to actively pump its substrates out of the cell. This could reduce the efficiency of absorption of common, orally absorbed drugs like digoxin, carbamazepine and propranolol. Recognition of the much broader specificity of P-gp and its functional effects on intestinal drug transport could lead to strategies for improving absorption, either by incorporating structural features in drug design that reduce interaction with P-gp or by the use of specific P-gp inhibitors.
 
The whole 5 pages article is available for download at Downloads section of Farmavita.Net. 
Comments
Add New Search RSS
Write comment
Name:
Email:
 
Website:
Title:
 
Please input the anti-spam code that you can read in the image.

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!
 
< Prev   Next >
Advertisement
 

Featured Partners

 
logo_kvadrat_150x150.jpg    
lcm-150x150.jpg  
bals134_150x150.jpg
150-150-static.gif
apacma13_150x150_banner.gif  
  doctors20150x1501.png
bals137_150x150.gif
bals138_150x150.jpg
ch-150x150-an.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 26 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

150-150-static.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif